JP2021510522A5 - - Google Patents
Info
- Publication number
- JP2021510522A5 JP2021510522A5 JP2020538958A JP2020538958A JP2021510522A5 JP 2021510522 A5 JP2021510522 A5 JP 2021510522A5 JP 2020538958 A JP2020538958 A JP 2020538958A JP 2020538958 A JP2020538958 A JP 2020538958A JP 2021510522 A5 JP2021510522 A5 JP 2021510522A5
- Authority
- JP
- Japan
- Prior art keywords
- aav
- envelope
- item
- aav particle
- particle
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023146391A JP2023160938A (ja) | 2018-01-11 | 2023-09-08 | 免疫回避性ベクターおよび遺伝子療法のための使用 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862616167P | 2018-01-11 | 2018-01-11 | |
| US62/616,167 | 2018-01-11 | ||
| US201862768779P | 2018-11-16 | 2018-11-16 | |
| US62/768,779 | 2018-11-16 | ||
| PCT/US2019/013361 WO2019140311A1 (en) | 2018-01-11 | 2019-01-11 | Immuno-evasive vectors and use for gene therapy |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023146391A Division JP2023160938A (ja) | 2018-01-11 | 2023-09-08 | 免疫回避性ベクターおよび遺伝子療法のための使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021510522A JP2021510522A (ja) | 2021-04-30 |
| JP2021510522A5 true JP2021510522A5 (https=) | 2022-02-07 |
| JP7406253B2 JP7406253B2 (ja) | 2023-12-27 |
Family
ID=65444323
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020538958A Active JP7406253B2 (ja) | 2018-01-11 | 2019-01-11 | 免疫回避性ベクターおよび遺伝子療法のための使用 |
| JP2023146391A Pending JP2023160938A (ja) | 2018-01-11 | 2023-09-08 | 免疫回避性ベクターおよび遺伝子療法のための使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023146391A Pending JP2023160938A (ja) | 2018-01-11 | 2023-09-08 | 免疫回避性ベクターおよび遺伝子療法のための使用 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20200338216A1 (https=) |
| EP (1) | EP3737768A1 (https=) |
| JP (2) | JP7406253B2 (https=) |
| KR (1) | KR20200128519A (https=) |
| CN (1) | CN111836896A (https=) |
| AU (1) | AU2019206639A1 (https=) |
| BR (1) | BR112020014093A2 (https=) |
| CA (1) | CA3088897A1 (https=) |
| CL (1) | CL2020001850A1 (https=) |
| IL (1) | IL275951A (https=) |
| MX (1) | MX2020007390A (https=) |
| RU (1) | RU2020126574A (https=) |
| SG (1) | SG11202006298XA (https=) |
| WO (1) | WO2019140311A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4118219A4 (en) * | 2020-03-11 | 2024-04-17 | Shanghai Belief-Delivery Biomed Co., Ltd. | Novel use of aspirin compound in increasing nucleic acid expression |
| US20230355803A1 (en) * | 2020-06-24 | 2023-11-09 | Chameleon Biosciences, Inc. | Extracellular vesicles with immune modulators |
| CN112410304A (zh) * | 2020-11-12 | 2021-02-26 | 天津大学 | 一种基因修饰的外泌体及其制备方法和应用 |
| WO2023028035A1 (en) * | 2021-08-23 | 2023-03-02 | University Of Florida Research Foundation, Incorporated | Lipid enveloped recombinant aav particles for gene therapy use |
| EP4660308A1 (en) * | 2023-01-31 | 2025-12-10 | Synplogen Co., Ltd. | Helper gene |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU8672198A (en) | 1997-07-31 | 1999-02-22 | Chiron Corporation | Method enabling readministration of aav vector via immunosuppression of host |
| WO1999055893A1 (en) | 1998-04-29 | 1999-11-04 | University Of Southern California | Retroviral vectors including modified envelope escort proteins |
| DE19827457C1 (de) * | 1998-06-19 | 2000-03-02 | Medigene Ag | Strukturprotein von AAV, seine Herstellung und Verwendung |
| EP1769078A1 (en) * | 2004-07-01 | 2007-04-04 | VIRxSYS Corporation | Vector packaging cell line |
| WO2006138670A2 (en) | 2005-06-16 | 2006-12-28 | Virxsys Corporation | Antibody complexes |
| JP4691611B1 (ja) | 2010-01-15 | 2011-06-01 | 富士フイルム株式会社 | 有機電界発光素子 |
| WO2011106376A2 (en) * | 2010-02-23 | 2011-09-01 | The General Hospital Corporation | Use of microvesicles in the treatment of medical conditions |
| JP7242180B2 (ja) * | 2014-09-07 | 2023-03-20 | セレクタ バイオサイエンシーズ インコーポレーテッド | 抗ウイルス導入ベクター免疫応答を減弱化するための方法および組成物 |
| CN104887717B (zh) * | 2015-06-04 | 2019-05-31 | 爱康得生物医学技术（苏州）有限公司 | 一种免疫增强试剂 |
| WO2017136764A1 (en) * | 2016-02-05 | 2017-08-10 | The General Hospital Corporation | Hybrid system for efficient gene delivery to cells of the inner ear |
-
2019
- 2019-01-11 BR BR112020014093-7A patent/BR112020014093A2/pt not_active IP Right Cessation
- 2019-01-11 EP EP19705841.5A patent/EP3737768A1/en not_active Withdrawn
- 2019-01-11 AU AU2019206639A patent/AU2019206639A1/en not_active Abandoned
- 2019-01-11 CA CA3088897A patent/CA3088897A1/en active Pending
- 2019-01-11 CN CN201980018276.3A patent/CN111836896A/zh active Pending
- 2019-01-11 RU RU2020126574A patent/RU2020126574A/ru unknown
- 2019-01-11 WO PCT/US2019/013361 patent/WO2019140311A1/en not_active Ceased
- 2019-01-11 JP JP2020538958A patent/JP7406253B2/ja active Active
- 2019-01-11 KR KR1020207022774A patent/KR20200128519A/ko not_active Ceased
- 2019-01-11 SG SG11202006298XA patent/SG11202006298XA/en unknown
- 2019-01-11 US US16/961,500 patent/US20200338216A1/en not_active Abandoned
- 2019-01-11 MX MX2020007390A patent/MX2020007390A/es unknown
-
2020
- 2020-07-09 IL IL275951A patent/IL275951A/en unknown
- 2020-07-10 CL CL2020001850A patent/CL2020001850A1/es unknown
-
2023
- 2023-09-08 JP JP2023146391A patent/JP2023160938A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Pupo et al. | AAV vectors: The Rubik’s cube of human gene therapy | |
| JP7561788B2 (ja) | 臨床使用に適した無血清懸濁細胞培養システムにおいて組換えアデノ随伴ウイルス（ａａｖ）ベクターを産生するスケーラブルな方法 | |
| JP2021510522A5 (https=) | ||
| EP3250239B1 (en) | Capsid | |
| CA2919103C (en) | Variant aav and compositions, methods and uses for gene transfer to cells, organs and tissues | |
| JP2025148444A (ja) | 未成熟終止コドン媒介障害を処置するための方法および組成物 | |
| KR20200033840A (ko) | 개선된 세포 트랜스펙션 및/또는 rAAV 벡터 생산을 위한 증진제 | |
| CN115151647B (zh) | Dna扩增方法 | |
| RU2020126574A (ru) | Векторы, ускользающие от иммунного надзора, и их применение в генотерапии | |
| JP2022544004A (ja) | 操作された核酸調節エレメントならびにその使用方法 | |
| US20210299279A1 (en) | Methods and compositions for treating a premature stop codon-mediated disorder | |
| US20240384300A1 (en) | Methods and compositions for treating a premature termination codon-mediated disorder | |
| Fuchs et al. | Recombinant AAV vectors for enhanced expression of authentic IgG | |
| CA3114108A1 (en) | Methods and compositions for treating a premature stop codon-mediated disorder | |
| CN111876432A (zh) | 一组肝靶向新型腺相关病毒的获得及其应用 | |
| US20240167054A1 (en) | Method of producing a recombinant virus particle | |
| WO2022159702A1 (en) | Microtubule destabilizer additives to increase recombinant viral vector titers | |
| US20240084329A1 (en) | Improved production of recombinant polypeptides and viruses | |
| WO2024050547A2 (en) | Compact bidirectional promoters for gene expression | |
| Moço | Improving adeno-associated virus serotype 6 production and transduction for gene delivery and CAR T-cell therapy | |
| WO2025085957A1 (en) | Adeno-associated virus (aav) receptors and uses therefor | |
| Martin | Development and Characterisation of HEK293T Cell Expression Systems for Enhanced Production of Recombinant AAV Viral Vectors | |
| HK40061787A (en) | Dna amplification method | |
| WO2024091495A1 (en) | Compositions and methods for treating retinitis pigmentosa | |
| Askou et al. | Somatic gene therapy using viral vectors: Theoretical and clinical implications in relation to treatment of genetic conditions in humans |